Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 12.34
+0.24 (1.98%)
May 7, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 8.84 billion as of May 7, 2026. Its market cap has increased by 107.65% in one year.
Market Cap
8.84B
Enterprise Value
6.52B
Revenue
681.17M
Ranking
n/a
PE Ratio
125.38
Stock Price
12.34
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 8.84B, an increase of 1.50%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 8.84B | 1.07% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 12.09B |
| CARsgen Therapeutics Holdings | 11.36B |
| HBM Holdings | 10.92B |
| Alphamab Oncology | 9.83B |
| Shanghai Haohai Biological Technology | 9.41B |
| Lepu Biopharma | 9.08B |
| Shanghai Bao Pharmaceuticals | 8.48B |
| CK Life Sciences Int'l., (Holdings) | 7.11B |